ENRIQUE
ALAVA CASADO
Ikertzailea 2012-2013 tartean
Instituto de Biomedicina de Sevilla
Sevilla, EspañaInstituto de Biomedicina de Sevilla -ko ikertzaileekin lankidetzan egindako argitalpenak (1)
2015
-
Trabectedin efficacy in Ewing sarcoma is greatly increased by combination with anti-IGF signaling agents
Clinical Cancer Research, Vol. 21, Núm. 6, pp. 1373-1382